VA, G., TA, O., U, G., N, E., LA, F., NS, G., . . . A, P. (2026). Risk factors for CRS and ICANS with Bispecific Antibodies for Aggressive Lymphomas. Blood advances. https://doi.org/10.1182/bloodadvances.2026020595
Chicago Style (17th ed.) CitationVA, Gill, et al. "Risk Factors for CRS and ICANS with Bispecific Antibodies for Aggressive Lymphomas." Blood Advances 2026. https://doi.org/10.1182/bloodadvances.2026020595.
MLA (9th ed.) CitationVA, Gill, et al. "Risk Factors for CRS and ICANS with Bispecific Antibodies for Aggressive Lymphomas." Blood Advances, 2026, https://doi.org/10.1182/bloodadvances.2026020595.
Warning: These citations may not always be 100% accurate.
